2269.T
Stock Details
2269.T is Meiji Holdings Co., Ltd.'s stock. Stock exchange Tokyo (Currency JPY). Average price in 50 days is 6,258.00ï¿¥. Average daily volumn in 3 months 509.4k. Market cap 879.55B
Stock symbol : 2269.T. Exchange : Tokyo. Currency : JPY Lastest price : 3,155.00ï¿¥. Total volume : 1.26M. Market state CLOSED Click reload if you want to check the lastest price on market!!!
Meiji Holdings Co., Ltd. (2269.T)
Last Price
3,155.00ï¿¥Change
5.00Volume
1.26M
| Previous Close | 3,150.00 |
| Open | 3,155.00 |
| Day Range | 3,150.00-3,185.00 |
| Bid | 3,150.00 x N/A |
| Ask | 3,165.00 x N/A |
| Volume | 1.26M |
| Average Volume | 509.4k |
| Market Cap | 879.55B |
| Beta | 0.08 |
| 52 Week Range | 3,145.00-7,130.00 |
| Trailing P/E | 11.35 |
| Foward P/E | 15.73 |
| Dividend (Yield %) | 2.69% |
| Ex-Dividend Date | 2023-03-30 |
Financial Details
Organization
Meiji Holdings Co., Ltd., through its subsidiaries, manufactures and sells dairy products, confectioneries, nutritional products, and pharmaceuticals in Japan and internationally. The company operates through two segments, Food and Pharmaceutical. It provides yogurt, cheese, drinking milk, beverages, butter and margarine, cream, ice cream, ready meals, chocolates, gummy products, chewing gums, sports nutrition products, infant formula, liquid diet, beauty supplements, OTC medicines, feed stuffs,... corn sweeteners, and sugar, as well as transportation and distribution services. The company also offers drugs for infectious diseases and central nervous system disorders, as well as generic drugs; agricultural and livestock chemicals; human and animal vaccines, and blood plasma products; and veterinary drugs for livestock and fisheries comprising antimicrobial injection, disinfectants, oral administration, insecticides, anthelmintic, antipyretic, analgesic, anti-inflammatory, hemostatic, and breeding agents. In addition, it provides insecticides, metabolites, feed additives, and mixed feed; and companion animals, including anesthetics and painkillers, anti-parasitic and gastrointestinal drugs, anti-bacterial agents, antiplasmin agents, vitamin E preparations, and dietary supplements. Meiji Holdings Co., Ltd. was founded in 1916 and is headquartered in Tokyo, Japan.
Market Cap:
879.55BRevenue:
1.01TTotal Assets:
1.12TTotal Cash:
67.41B
News about "Meiji Holdings Co., Ltd."
Meiji Holdings Co. Ltd. ADR
Source from : Wall Street Journal - 12 days ago
1 Day MEJHY -0.38% DJIA 1.20% S&P 500 0.89% Consumer Goods 0.28% Kazuo Kawamura President & Representative Director Global Dairy Platform, Meiji Holdings Co., Ltd., Meiji Co., Ltd., Japan Dairy ...See details»
Meiji Holdings
Source from : Forbes - 9 days ago
Meiji Holdings Co., Ltd. engages in the management of its subsidiaries with business activities focusing on food and pharmaceutical production. It operates through the Food and Pharmaceutical ...See details»
Meiji Holdings Co., Ltd. (2269.T)
Source from : Yahoo Finance - 20 hours ago
*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...See details»
Meiji Holdings Co Stock (OTC:MEJHF), Dividends
Source from : Benzinga.com - 6 month ago
Meiji Holdings Co issues dividends to shareholders from excess cash Meiji Holdings Co generates. Most companies pay dividends on a quarterly basis, but dividends may also be paid monthly ...See details»
Infant Formula Ingredients Global Market Report 2023: Focus on Infant Care and Nutrition is Expected to Drive the Market
Source from : YAHOO!Finance - 2 days ago
This report provides strategists, marketers and senior management with the critical information they need to assess the market.The global infant formula ingredients market grew from $19.77 billion in ...See details»
Yogurt Market 2023 Size and Forecast to 2030
Source from : MarketWatch - 5 days ago
Yogurt Marketinformation for each competitor includes (Nestle, Arla Foods, Yakult, Chobani LLC, Bright Food (Group) ...See details»
Meiji Yasuda Life Insurance Company
Source from : BN Americas - 2 years ago
Subscribe to the most trusted business intelligence platform in Latin America. Let us show you our solutions for Suppliers, Contractors, Operators, Government, Legal, Financial and Insurance.See details»
Why Arcturus Therapeutics Shares Are Moving Higher After Hours
Source from : Business Insider - 3 days ago
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) shares are booming in Tuesday's after-hours session after the company reported fourth-quarter results and provided an update on ...See details»
Beauty Supplements Market Size From 2023 To 2029 And Unlimited Opportunities for New Companies
Source from : MarketWatch - 3 days ago
To know How COVID-19 and Russia-Ukraine War Influence Will Impact This Market/Industry - Request a sample copy of the report-: Moreover, the Beauty Supplements Market Report includes data on research ...See details»
Arcturus Therapeutics Stock Is Rising Wednesday: What's Going On?
Source from : Business Insider - 3 days ago
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) shares are trading higher Wednesday after the company reported strong fourth-quarter results and provided an update on pipeline progress.See details»
Why Arcturus Therapeutics Stock Is Soaring Today
Source from : The Motley Fool on MSN - 3 days ago
Arcturus handily topped analysts' estimates on both the top and bottom lines. And the company provided an update on its pipeline progress. It said that its partner, Meiji Pharma, completed full ...See details»
Truly International Holdings
Source from : Forbes - 3 days ago
Truly International Holdings Ltd. operates as an investment holding company. The company through its subsidiaries engages in the manufacturing and selling of liquid crystal display products and ...See details»
The Tata Power Company Ltd.
Source from : moneycontrol.com - 1 days ago
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.See details»
The Global Doxorubicin Market is forecast to grow by $469.97 mn during 2022-2027, accelerating at a CAGR of 6.07% during the forecast period
Source from : Yahoo Finance - 10 days ago
The analyst has been monitoring the doxorubicin market and is forecast to grow by $469.97 mn during 2022-2027, accelerating at a CAGR of 6.07% during the forecast period.New York, March 22, 2023 ...See details»